Skip to content

Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus

Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00381771
Enrollment
340
Registered
2006-09-28
Start date
2006-02-28
Completion date
2007-12-31
Last updated
2010-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Globus Pharyngeus

Keywords

Globus Pharyngeus, Xerostomia, Salivary Hypofunction, Pharyngoxerosis

Brief summary

It is well known that 'globus sensation in throat' is caused by the chronic irritation and inflammation of oral, pharyngeal, or laryngeal mucosa, such as laryngopharyngeal reflux and chronic postnasal drip. Xerostomia and pharyngoxerosis due to salivary hypofunction also proved to induce the mucosal change of the oral cavity and pharynx. However, no previous studies have documented the prevalence of salivary hypofunction in patients with globus pharyngeus. Through this clinical investigation, we hypothesized that the salivary hypofunction might be one of the leading cause of globus pharyngeus.

Detailed description

Subjects: patients with symptoms of globus pharyngeus Globus symptom scoring: 0(mild) to 5(severe) Subjective symptom analysis by Standard Table for Xerostomia and Pharyngoxerosis Subjective physical finding analysis by Standard Table for Xerostomia and Pharyngoxerosis Objective analysis of Salivary function by 99m-Tc Salivary scintigraphy --\> Define the prevalence of salivary hypofunction in patients with globus pharyngeus (Primary end point) Subsequent analysis (Secondary end point) 1. Group 1: Globus patients with objective salivary hypofunction 2. Group 2: Globus patients with normal salivary function Intervention: Active management for xerostomia (Moisturizing, Gargling, Humidification, Massage of salivary gland, Stimulant of salivary secretion, Artificial saliva) Evaluation of the change of globus symptoms after active management of xerostomia between the Group 1 and Group 2 (at 1 months, at 3 months after the initiation of intervention)

Interventions

BEHAVIORALConservative management for xerostomia

Active hydration (drinking more than 10 cups of water per day), Humidification, Oral gargle with a diluted (0.05% to 0.1%) chlorhexidine solution, Sugarless chewing gum, Saliva-stimulating sour juice (sugarless orange juice), Commercial artificial saliva, Nasal saline spray 3 to 4 times a day, Warm massage of the 4 major salivary glands.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Subjects with globus pharyngeus symptoms

Exclusion criteria

* Subjects with tumors in oral cavity, oropharynx, nasopharynx, hypopharynx, which may cause globus symptoms * subjects, who do not undergo the endoscopic exam for the upper aerodigestive tract including oral cavity, oropharynx, nasopharynx, hypopharynx. * subjects, who take medications that may have potential effect on the mucosa of the upper aerodigestive tract including oral cavity, oropharynx, nasopharynx, hypopharynx. * subjects with poor medical performance (\<70%)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026